Nuclear magnetic resonance solution conformation of α-conotoxin AuIB, an α3ß4 subtype-selective neuronal nicotinic acetylcholine receptor antagonist by Olivera, Baldomero M. & Cho, Jee-Hyun
The Journal of Biological Chemistry
© 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Vol. 275, No. 12, Issue of March 24, pp. 8680-8685, 2000
Printed in U.S.A.
Nuclear Magnetic Resonance Solution Conformation of a-Conotoxin 
AuIB, an a3p4 Subtype-selective Neuronal Nicotinic Acetylcholine 
Receptor Antagonist*
(Received for publication, October 4, 1999, and in revised form, December 17, 1999)
Je e -H y u n  C h o i, K. H u n  M okf, B a ld o m ero  M. O liveraS , J .  M ich ae l M cIntoshSU, K yu-H w an  P a rk f ,  
a n d  K you-H oon H a n i
From the %Protein Engineering Laboratory, Korea Research Institute o f Bioscience and Biotechnology, Yusong, Taejon 305­









The n eu ro n a l n ico tin ic  acety lcho line recep to rs  co nsti­
tu te  a  h igh ly  d iverse  group , w ith  sub types consisting  of 
p en tam eric  com binations o f a  an d  [i subun its . a-Cono- 
tox ins a re  a  hom ologous se ries  of sm all p ep tid es  th a t  
an tagon ize  th ese  recep to rs . We p re se n t th e  th ree-d im en ­
sional so lu tion  s tru c tu re  o f a-conotoxin  AuIB, th e  f irs t 
15-residue a-conotoxin  know n to  selectively b lock  th e  
a 304 n ico tin ic  acety lcholine re c e p to r subtype. The p a ir ­
w ise backbone a n d  heavy-atom  ro o t m ean  sq u are  devi­
a tio n  fo r  an  ensem ble o f 20 s tru c tu re s  a re  0.269 an d  0.720 
A, respectively . The overa ll fo ld  o f a-conotoxin  AuIB 
closely resem bles th a t  o f th e  a4/7 subfam ily a-conotox­
ins. H ow ever, th e  absence of T y r15, norm ally  p re se n t in  
o th e r  a4/7 m em bers, re su lts  in  tig h t bend in g  o f th e  b ack ­
bone a t  th e  C te rm in u s  an d  effectively re n d e rs  A sp14 to  
assum e th e  sp a tia l location  o f T y r15 p re se n t in  o th e r 
n eu ro n a l a4/7 a-conotoxins. S tru c tu ra l com parison  of 
a-conotoxin  AuIB w ith  th e  a 302 subtype-specific  a-cono­
tox in  M II show s d iffe ren t e lec tro sta tic  su rface  charge 
d is trib u tio n s, w hich  m ay be im p o rtan t in  d iffe ren tia l 
re c e p to r subtype recognition .
The a-conotoxins are small neuropharmacologically active 
peptides of Conus origin that antagonize the nicotinic acetyl­
choline receptor (nAChR)1 (1). The natural diversity of biosyn­
thesized conotoxin peptides has led to the classification of a 
wide spectrum of disulfide-bridged peptides, which attack var­
ious ligand and ion-gated channels and receptors (1). The nic­
otinic acetylcholine receptors exhibit considerable diversity in 
their own right because of the different compositions found in 
the pentameric subunits constituting each nAChR subtype (2). 
Although the mammalian neuromuscular subtype comprises 
(“ i hfiyS or (“ 1)2 subunits, the neuronal subtypes are com­
paratively more diverse with their hetero- or homopentameric 
combinations of a (a2 ~ a 9) or j3 (/32 ~ 04) subunits (3, 4). The
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general conotoxin strategy of diversification is “combinatorial” 
(5), in which amino acid residues are varied within a given 
disulfide framework to specifically and selectively bind various 
subtypes of the target channel or receptor. For the case of 
a-conotoxins, target selectivity is essentially defined depending 
on which subunit interface of the nAChR (e.g. ctjy, a /8 , and 
a3/j32) each individual a-conotoxin preferentially binds to (1). 
Highly selective a-conotoxins tha t permit differential blocking 
of diverse nAChR subtypes have served as effective tools in 
studying these receptors (1).
Of recent particular interest are the a-conotoxins that act on 
neuronal nAChRs. For example, a-conotoxin AuIB specifically 
targets the a3j34 subtype (6), whereas a-conotoxin MII selec­
tively blocks the a302 subtype (7). On the other hand, a-cono­
toxin Iml, the smallest of all a-conotoxins and distinct because 
of its a4/3 disulfide framework2, is a specific antagonist of the 
homomeric a 7 subtype (8). In addition, other neuronal a-cono­
toxins such as PnIA (9), PnIB (9), and EpI (10) that are less 
selective to a particular nAChR subtype have also been iden­
tified (Table I).
As shown in Table I, most neuronal a-conotoxins belong to 
the a4/7 subfamily, in which the amino acid sequence varies 
within disulfide bridge-enclosed loops of 4 and 7 residues. In­
terestingly, a-conotoxin EI, unique in its specificity for the a /8  
subunit interface in Torpedo neuromuscular nAChR, belongs to 
the same a4/7 subfamily (11). The recent increase in the un­
derstanding of these conotoxins has been attributable to the 
advances in the structural characterization of these molecules. 
High-resolution three-dimensional structures of a4/7 subfam­
ily a-conotoxins PnIA (12), PnIB (13), MII (14, 15), and 
[Tyr15]EpI (16) show that, when backbone-superimposed, their 
backbone fold is extremely similar. The recently solved NMR 
structure of a-conotoxin EI also has the same overall molecular 
fold as the a4/7 neuronal a-conotoxins3 despite the variation in 
its sequence both within the disulfide loops and at the N ter­
minus (Table I). These observations reaffirm that conotoxins 
are based on common three-dimensional scaffolds and that 
their subtype selectivity is conferred through sequence varia­
tion of a selected number of residues (5).
Through structural elucidation of these highly selective 
a-conotoxins and their analogs (17,18), we have been using the 
reverse-mapping approach first to identify receptor subtype 
specific determinants in the ligands and second to indirectly 
probe the regions in nAChR responsible for binding agonists
2 The a-conotoxins are additionally grouped according to the number 
of amino acid residues enclosed within each disulfide loop. Loop sizes of 
four residues in the first loop and seven in the second are denoted as 
ff4/7. Other subfamilies include ti3/5 and ff4/3.
3 K.-H. Park. J. E. Suk. R. Jacobsen. W. R. Gray. J. M. McIntosh. 
B. M. Olivera. and K. Han. manuscript in preparation.
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Table I
Amino acid sequences o f a4!7 subfamily a-conotoxins that target 
neuronal nAChR
All listed a-conotoxins are neuronal toxins except El, which is a 









Name Sequence Specificity Reference
AuIB GCCSYPPCFATNP-DC* “30i 6
AuIC GCCSYPPCFATNSGYC* “30i 6
AuIA GCCSYPPCFATNSDYC* “30i 6
Mil GCCSNPVCHLEHSNLC* “ 302 7
PnIA GCCSLPPCAANNPDYC* “302 36
PnIB GCCSLPPCALSNPDYC* “ 7 36
EpI GCC SDPRCNMNNPDYC * “302’ “304 10
ImP GCCSDPRCA— W-R-C* 17, 18
EI RDOCCYHPTCNMSNPQIC* Qjfi 11
° Q-Conotoxin 1ml is an a-4/3 conotoxin.
and antagonists. We hereby present the high-resolution solu­
tion structure of a-conotoxin AuIB that has a unique a3j34 
nAChR subtype selectivity (6). a3j34-]ike receptors are believed 
to be important in peripheral ganglionic transmission and cen­
trally mediated norepinephrine release. a-Conotoxin AuIB in­
herently lacks Tyr16 found in other a4/7 members such as 
a-conotoxins PnIA, PnIB, EpI, and even AuIA and AuIC (Table 
I). Of the three a-conotoxin Auls found in Conus aulicus (6), 
a-conotoxin AuIB is the best characterized from a functional 
standpoint and has thus been chosen for detailed structural 
analysis by NMR. Structural comparison of a-conotoxin AuIB 
with other neuronal a-conotoxins should provide useful insight 
into important nAChR subtype determinants, in particular, 
those that discriminate the ji2 and ji4 subunits.
EXPERIMENTAL PROCEDURES
Peptide Synthesis and Purification—a-Conotoxin AuIB was synthe­
sized using solid-phase chemistry and purified to homogeneity as de­
scribed previously (6).
NMR Spectroscopy—Sam pies for NMR studies were prepared in 90% 
H20  and 10% 2H20  or 100% 2H20, pH 4.1, with a final sample concen­
tration of 6 mM. All NMR experiments were performed using a Varian 
UNITY INOVA 600 spectrometer at 278 and 298 K. Solvent suppres­
sion was carried out using selective, low-powered irradiation of the 
water resonance during a relaxation delay of 1.5 s. All resonances were 
referenced to a residual water signal (4.76 ppm at 298 KJ. Mixing times 
of 200-400 ms for NOESY and 150 ms for rotating frame NOESY 
experiments were used. For total correlation spectroscopy experiments 
(19J, a 75-ms mixing time was used. V h sh . coupling constants for the 
backbone torsion angle were measured using phase-sensitive double­
quantum-filtered two-dimensional COSY experiments (20J. Primitive 
exclusive COSY (21J was performed in 100% 2H20  to measure the 
3t/nfJcoupling constants, which were used in conjunction with the d NfJ 
NOEs to provide x1 torsion angles. Spectral widths were 7.0 kHz in both 
dimensions. Typical two-dimensional data consisted of 2048 complex 
points in the t2 dimension and 256 complex t t increments. Data acqui­
sition, sequential assignments, and spectral interpretation were per­
formed on SPARCstation IPX and Ultra 1 Creator workstations (Sun 
MicrosystemsJ running VnmrX 5.3B software (Varian AssociatesJ
Computation o f Structures—Two-dimensional NMR data were proc­
essed using Felix 95.0 and Insight 11 97.0 (Biosym/MSlJ on lndigo2 xL 
or Indy workstations (Silicon GraphicsJ. NOE interproton distance con­
straints were derived primarily from the NOESY spectrum obtained at 
278K with a mixing time of 200 ms. Before Fourier transformation, free 
induction decays were reconstructed using linear prediction, apodized 
with a 60° sine bell-squared window function in both dimensions, and 
baseline corrected using the FLATT algorithm (22J. NOE cross-peak 
volumes were measured and converted into upper bounds of interproton 
distances using the distance of 1.8 A as a reference for nonoverlapping 
geminal 8-proton cross-peaks. Appropriate pseudoatom allowances of
1.5-2.5 A were given to constraints. Dihedral angle restraints were 
inferred from 3t/HNIHn,coupling constants and were centered on - 120° ± 
30° for 3t/HNHn > 8 Hz and -60° ± 30° for V HN„„ < 6 Hz. Side chain ^  
torsion angles measured from primitive exclusive COSY experiments 
were also incorporated in combination with the sequential dnfi NOE for 
stereospecifically assigned p-methylene protons. A total of 156, includ­
ing 13 long-range and 25 medium-range, distance constraints, together
with eight <#> and two x l torsion angles were input for the computation 
of structures.
Preliminary structures were generated using DG11 (23J, NMRchitect, 
and Insight 11 97.0. An extended molecule with two disulfide bridges 
and a formal charge of zero was constructed. The potentials and partial 
charges were assigned using the consistent valence force field (24J and 
used throughout the computations. Full relaxation matrix analysis 
using MARD1GRAS version 3.2 (25J was performed on DGll-generated 
structures as initial model structures. The three-site jump model for 
intra- and inter-residue distances was chosen, and the noise level was 
estimated to be 50% of the un-normalized absolute value of the smallest 
peak. The rotational correlation time was estimated to be 1.0 ns.
Structures were refined with restrained molecular dynamics calcu­
lations with Discover 2.9.7 (Biosym/MSlJ and Insight li  95.0. A simu­
lated annealing schedule based on well established protocols (26J was 
generated and run. The 68-ps protocol consisted of dynamics at 1000 K 
(50 psj, followed by gradual temperature cooling from 1000 to 300 K 
(incremental temperature decrease of 100 K each over 18 psj with 
staggered geometric increases of NOE, covalent term, and nonbonded 
force constants. During the final dynamics step at 300 K and subse­
quent minimization steps, a modified restraint file with decreased force 
constants for side chain interproton distances was used to allow further 
conformational dynamics. Energy minimization was performed 2-fold, 
first with a quadratic potential and then with a Lennard-Jones non­
bonded potential. A total of 50 simulated annealing rounds were run.
Assessment o f Structure Quality and Visualization o f Structures— 
The R a and R h factors (27J were calculated using CORMA version 5.2 
(28J for the final ensemble of 20 structures. In addition, the stereochem­
istry of the computed structures were analyzed with PROCHECK ver­
sion 3.5 (29J. The three-dimensional display of structures was per­
formed either with Insight II 97.0 (Biosym/MSlJ or GRASP version 1.3.6 
(30J.
RESULTS
Resonance Assignment and Secondary Structure—The com­
plete 1H resonance assignment for a-conotoxin AuIB was 
achieved in a straightforward manner using double-quantum- 
filtered two-dimensional COSY, total correlation spectroscopy, 
and NOESY and rotating frame NOESY spectra following the 
standard sequential assignment procedure (31). Initial assign­
ment of the amino acids was made along the NH resonances in 
double-quantum-filtered two-dimensional COSY and total cor­
relation spectroscopy spectra. Apart from Thr11, where the Ha 
and Hj3 protons showed overlapping, all Ha and side chain 
protons were unambiguously resolved, permitting the tracing 
of sequential Ha-NH(i + 1) connectivities. The connectivity 
was broken at three proline residues (Pro6, Pro7, and Pro13), for 
which resonance assignment was achieved using strong 
d (vS(Tyr6, Pro6), d (vS(Pro6, Pro7), and d (vS(Asn12, Pro13) cross­
peaks that indicate all prolines have the trans conformation. 
Fig. 1 is a summary of sequential and medium-range NOEs 
used for the resonance assignment, the 3e7HNH„ values, the 
temperature coefficients for NH protons (A8NH), and chemical 
shift indices (32). The stretches of d„N(i, i + 3), dafi(i, i + 3), and 
d (vN(i, i + 4) NOEs between Pro6 and Asn12 makes the presence 
of an a-helix evident before the detailed structure calculations.
Structure Calculations—Fig. 2 shows the superposition of a 
final ensemble of 20 lowest energy structures. The backbone 
and heavy atom RMSD values for the entire chain are 0.269 
and 0.720 A, respectively. Omitting the flexible N-terminal 
Gly1 residue, the backbone RMSD value improves considerably 
to 0.092 A, with the heavy atom RMSD being 0.707 A. As shown 
in Table II, overall structural statistics concerning experimen­
tal restraints, covalent geometry, and structural convergence 
for a-conotoxin AuIB are extremely good. When subject to 
quality evaluation by PROCHECK (29), backbone dihedral an­
gles of all non-Gly and non-Pro residues were found to reside 
within the most favored region of the Ramachandran plot 
(Table II).
Three-dimensional Structure of a-Conotoxin Au.IB—The 
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F ig. 1. Sum m ary of sequen tia l and  
m edium -range NOE connectiv ities, 
'V HNH„ coupling constan ts, NH tem ­
p e ra tu re  coefficients (ASNH), and  
chem ical sh ift indices fo r cc-cono- 
tox in  AuIB. The thickness of the  bars is 
proportional to the  NOE intensity, classi­
fied as strong, medium, or weak. Filled 
circles denote 3-JHNH„ values of <6.0 Hz; 
open circles indicate 3-iHNH„ values of 
>8.0 Hz. For the  NH tem perature  coeffi­
cients, filled triangles denote ASNH <3 
ppta/K. Chemical shift index values of +1, 
0, and - 1  are represented as above, no 










Fig. 2. Stereo  view  of th e  20 final 
s tru c tu re s  of a-conotoxin AuIB su­
perim posed  over backbone atom s (N, 
C", C', and  O) of res idues 2-15. Se­
lected residues are labeled.
Table II
N M R structure determination statistics o f a-conotoxin A uIB  for an 
ensemble o f 20 structures
RMS deviations from Experim ental restraints"
Interproton distances (A) 0.0222 ± 0.0019
Torsion angle violation (°) 0.3663 ± 0.0311
Ramachandran plot statistics
Residues in most favored region (%) 100.0
Residues in additionally allowed region (%) 0.0
Residues in generously allowed region (%) 0.0
Residues in disallowed region (%) 0.0
Ensemble R  factors" '’
ffa 0.425 ± 0.005
0.139 ± 0.006
RMS deviations from th e  average structure
Residues 2-15
Backbone atom s'/heavy atoms (A) 0.092/0.707
Residues 1-15
Backbone atoms/heavy atoms (A) 0.269/0.720
" Values are means ± S.D.
'’ Ra and values are computed as defined in Ref. 27.
Backbone atoms are N, C", C', and 0 .
letter u>, which is characteristic of all aAJl a-conotoxins (Fig. 3). 
The N-terminal Cys2-Tyr° residues constitute a type I /3-tum. 
This is followed by a two-turn a-helix (Tyr5-Asn12), which forms 
the bottom portion of the u> fold. The C terminus (Asn12-Cys15) 
forms a bend at Pro13 to properly complete the Cys3-Cysl0 
disulfide bridge. Of the two disulfide bridges present in a-cono- 
toxin AuIB, x 1 angles for the Cys3-Cys15 pair were determined 
experimentally and used to calculate a left-handed spiral con­
formation. The final ensemble of the Cys2-Cys8 disulfide bridge 
also converged well to a single, left-handed form. These disul­
fide conformations are in good agreement with those observed 
in high-resolution x-ray structures of other aAJl members such 
as a-conotoxins PnIA (12) PnIB (13) and [Tyr15]EpI (16). As
shown in Fig. 3, the inherent absence of a tyrosine between 
Asp14 and Cys15 in a-conotoxin AuIB does not influence the 
overall conformation of the Cys3-Cys15 disulfide bridge to any 
appreciable extent. However, this deletion renders the local 
backbone fold near Asp14 and Cys10 in a-conotoxin AuIB no­
ticeably different from tha t in other aAJl members (see Fig. 
5A). Two consecutive fi turns found at their C termini of other 
aAJl members are absent in a-conotoxin AuIB.
DISCUSSION
Structural Comparison with Other a4I7 a-Conotoxins—The 
aAJl subfamily of a-conotoxins share a common u) backbone 
fold, as demonstrated in Fig. 3. The pairwise backbone RMSDs 
of a-conotoxin AuIB with other aAJl members are 0.97 A with 
MII (Protein Data Bank file name, 1M2C), 0.61 A with PnIA 
(1PEN), 0.70 A with PnIB (1AKG), and 0.52 A with [Tyr15]EpI 
(1A0M). A common backbone scaffold shared by the aAJl mem­
bers would presumably provide an efficient means for combi­
natorial presentation of functional side chain moieties that 
specifically interact with the receptor (5). As shown in Table I, 
when excluding the neuromuscular-targeting a-conotoxin EI, 
the N-terminal disulfide loop of all aAJl subfamily members 
contains an SvP(P/V) sequence (v is a variable residue) except 
for a-conotoxin EpI, which is not particularly specific for one 
subtype. Ligand binding to the a subunit of nAChR is known to 
be primarily mediated by hydrophobic aromatic interactions 
(33-35). Surface characteristics of the putative SvP(P/V) region 
in aAJl a-conotoxins shown below by GRASP suggest that the 
mostly hydrophobic SvP(P/V) sequence may represent a com­
mon a3 subunit recognition face in neuronal aAJl members.
The variability in sequence across the C-terminal seven- 
residue loop is greater, in particular, for the first three resi­
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Fig. 3. R ibbon d iag ram s of five superim posed  s tru c tu re s  o f n eu ro n a l rv4/7 subfam ily a-conotoxins AuIB (green ; th is  w ork), MII 
(blue-, P ro te in  D ata B ank  file nam e, 1M2C), PnIA  (yellow, 1PEN), PnIB  (orange; 1AKG), and  E pI (red-, 1A0M). N  and C, N and C termini, 









same loop can reasonably be represented by (P/S)(D/N)(Y/L)C. 
Because this C-terminal sequence is shared, it is unlikely that 
this region is responsible for the different nAChR subtype 
specificities exhibited by each toxin. For example, both a-cono­
toxins AuIA and AuIC possess Tyr15 (Table I), yet their a 304 
subtype selectivity is only slightly weaker than a-conotoxin 
AuIB (6). Therefore, Gly14 in a-conotoxin AuIC and the missing 
Tyr15 a-conotoxin AuIB are not likely to be essential for defin­
ing the a304 subtype selectivity. As noted above, the missing 
Tyr15 from the PDYC sequence in a-conotoxin AuIB results in 
a different local backbone C-terminal fold from other a4/7 
members. Using a-conotoxin PnIA as a reference, divergence in 
the a-conotoxin AuIB backbone trace begins with Pro13, where 
the Pro rings of both a-conotoxins PnIA and AuIB display 
perpendicular orientations. A strong backbone bend follows, 
placing the Asp14 Ca of a-conotoxin AuIB closer to the Tyr15 Ca 
than the Asp14 Ca of a-conotoxin PnIA (Fig. 3). It remains to be 
seen whether the observed spatial shift of the Asp14 side chain 
contributes to the higher antagonistic activity of a-conotoxin 
AuIB than AuIA/C.
Fig. 4 shows electrostatic potential surfaces generated by 
GRASP (30) for a-conotoxins AuIB, PnIA, [Tyr15]EpI, and MII. 
The viewing direction is kept same as that in Fig. 3. The 
positively charged N terminus (upper left region) is observed for 
all four toxins. The upper right hydrophobic bulge corresponds 
to Tyr15 of a-conotoxins PnIA and [Tyr15]EpI or Leu15 in 
a-conotoxin MII. Note that the negatively charged Asp14 of 
a-conotoxin AuIB is found at the corresponding location. A deep 
cleft is observed in the left side of MII, but the corresponding 
site in a-conotoxins AuIB and EpI is filled with Tyr5 and Asp5, 
respectively. The conspicuous hydrophobic bulge formed by 
Leu10 in the middle of MII is absent in other a4/7 members, 
suggesting that Leu10 in MII is important for its f}2 subunit 
selectivity (see below). Significance of the residue at position 10 
in the a4/7 subfamily is further illustrated by the following 
observation. a-Conotoxins PnIA and PnIB differ in only two 
positions, yet their selectivities are markedly different (Table 
I). Interestingly, substituting Ala10 by Leu turns the a3f}2 sub­
type-specific PnIA into an a 7 subtype-specific toxin, suggesting 
that only position 10 is necessary to differentiate the two toxins 
(1).
Comparison o f a-Conotoxins AuIB ancl MII—As shown in 
Fig. 5, more specific comparison can be made between two 
members of the a4/7 subfamily, AuIB and MII, because the 
former is highly selective toward the a304 nAChR subtype, 
whereas the latter is selective for the a3f}2 subtype. MII is
Fig. 4. E lec tro sta tic  surface p o ten tia l rep re sen ta tio n s  of 
a-conotoxins AuIB, MII, [T yr^JEpI, an d  PnIA. The structures are 
oriented in the same direction as in Fig. 3 to place the N terminus on the 
upper left and the C terminus on the upper right. Some selected resi­
dues are labeled. Regions of the surface with electrostatic potentials 
greater than +15kT, equal to 0, and less than -15kT  are blue, white, 
and red, respectively. The atomic charges were taken from the consist­
ent valence force field (24), and the calculations and generation of the 
diagram were performed with GRASP (30).
chosen as the a3f}2 subtype-specific toxin, because a-conotoxin 
PnIA, another a 3j32-targeting toxin, is much less selective than 
a-conotoxin MII toward the same receptor subtype (1). At pres­
ent, two different NMR structures of MII are available, one 
determined in aqueous solution (Ref. 15; 1M2C) and the other 
in 30% 2,2,2-trifluoroethanol (Ref. 16; 1MII). Because the 
structure of a-conotoxin AuIB was determined in aqueous so­
lution without 2,2,2-trifluoroethanol, structural comparisons 
were made with the former. In fact, backbone comparisons of 
a-conotoxin AuIB with both structures indicate that the former 
agrees better when superimposed (pairwise RMSDs, 0.97 A for 

























Fig. 5. S tru c tu ra l com parison  betw een  tv-conotoxins AuIB {green) an d  MII (blue). A, ribbon diagrams showing the difference in the 
backbone near residues 13-15. B, Connolly surface comparison between two toxins. Three residues of Mil are exposed out of the AuIB surface and 
labeled. The viewing direction differs by 90° from A.
local backbone difference near residues 13-15 between a-cono­
toxins MII and AuIB. This difference is also clearly visible 
when the structure of a-conotoxin MII determined in 2,2,2- 
trifluoroethanol is used for comparison, because the structures 
of a-conotoxin MII in two solvent conditions are essentially the 
same.
If a comparative surface exposure approach previously used 
for a-conotoxin EI3 is applied to compare the two toxins (Fig. 
5B), three residues of a-conotoxin MII become exposed out of 
the AuIB surface, Leu10, Glu11, and His12. The former two were 
shown to be important for distinguishing neuromuscular from 
neuronal nAChR.3 Note that GRASP analysis above suggested 
Leu10 to be important for the f}2 subunit selectivity of a-cono­
toxin MIL The third residue, His12, is unique in tha t no other 
a4/7 members have such an aromatic bulky residue at the same 
position (Table I). Intriguingly, His12 is buried underneath 
bulky side chains of Arg9 and His10 of neuromuscular a-cono­
toxin GI and hence is not surface-exposed when a-conotoxins 
GI and MII are superimposed.3 These results suggest that 
His12 in a-conotoxin MII is important for distinguishing two 
different neuronal nAChR subtypes, a3j34 and a3j32, but makes 
no contribution to discriminating the neuronal nAChR subtype 
against the neuromuscular subtype.
The surface-exposed Ser13 of a-conotoxin MII is not consid­
ered important, because it stays outside of the AuIB surface 
because of the different local backbone topology pointed out 
earlier. This residue is not exposed if a-conotoxin MII is super­
imposed with other a4/7 members such as PnlA/B or EpI. 
Rather interesting is that there are no prominently protruding 
AuIB residues out of the MII surface, except for the hydroxyl 
tip of Tyr5 and the carboxylate side chain of Asp14. An alanine- 
scanning study on a-conotoxin AuIB should provide answers on 
the significance of these residues for the ji4 subtype specificity.
The structural details of a-conotoxin binding with nAChR 
are currently incomplete. Despite the overall differences or 
local similarity among these toxins, it is certainly difficult to 
unambiguously define the respective subtype selectivities 
based only on such structural features (18). Binding determi­
nants within the a4/7 subfamily are subtle and may not be 
immediately discernible, as can be judged from the fact that the 
overall structural fold is same, whereas only types of amino 
acids are varied. Hence, structural comparison of different 
a-conotoxins needs to be augmented by additional information 
from site-directed mutagenesis and chimeric receptor engineer­
ing (3, 36, 37). Cumulative results support tha t both a and 
non-a subunits of the neuronal nAChR contribute to the bind­
ing of agonists and antagonists (38^42), although the extent of 
contribution from different subunits to ligand binding needs to 
be better-characterized.
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